RT @DrMiniDey: SLR comparing the 4-dose ANCA #vasculitis (AAV) rituximab regimen (widely used in RCTs) to 2-dose #rheuma
Tweet Content
SLR comparing the 4-dose ANCA #vasculitis (AAV) rituximab regimen (widely used in RCTs) to 2-dose #rheumatoidarthritis RTX regimen (common in clinical practice), to induce AAV remission, finds no difference in efficacy or safety.
Abs#2048 #ACR20 @RheumNow
https://t.co/WBaWN9d8vs
Links
Comparison of Two Rituximab Regimens for Induction of Remission in Antineutroph…
https://acrabstracts.org/abstract/comparison-of-two-rituximab-regimens-for-indu…
Show on Archive Page
On
Display in Search Results
On